Labcorp Financial Statements
NYSE: LHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Labcorp revenue and earnings
In fiscal 2025, Labcorp generated $13.95 billion in revenue, up 7.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $876.5 million (+17.5% year over year), for a net margin of 6.3% versus a median of 10.8% in the prior 5 years. Gross margin was 28.8% (up from 27.9%) and operating margin 9.9%.
Diluted earnings per share came in at $10.46, up from $8.84. Over the last 5 fiscal years, LH's revenue has grown at a -0.0% compound annual rate (a contraction).
Summary generated from market data by MetaCap's automated system. Methodology
Labcorp income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20212022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B | 13.98B | 11.55B | 11.33B | 10.31B | 9.55B |
| Revenue growth (YoY) | +7.25% | +6.97% | +2.51% | -9.68% | -6.03% | +20.98% | +1.95% | +9.95% | +7.90% | +10.06% |
| Cost of Revenue | 9.94B | 9.38B | 8.80B | 8.15B | 8.14B | 9.03B | 8.30B | 8.16B | 7.22B | 6.70B |
| Gross Profit | 4.01B | 3.62B | 3.36B | 3.71B | 4.99B | 4.95B | 3.25B | 3.18B | 3.09B | 2.85B |
| Operating Expenses | 2.63B | 2.54B | 2.64B | 2.27B | 1.94B | 2.51B | 1.92B | 1.85B | 1.79B | 1.58B |
| Selling, General & Admin | 2.22B | 2.23B | 2.02B | 1.76B | 1.69B | 1.73B | 1.62B | 1.57B | 1.50B | 1.35B |
| Operating Income | 1.38B | 1.09B | 725.60M | 1.44B | 3.05B | 2.45B | 1.33B | 1.33B | 1.31B | 1.27B |
| Interest Expense | 224.10M | 208.30M | 199.60M | 179.80M | 211.80M | 207.40M | 240.70M | 244.20M | 235.10M | 219.10M |
| Other Income (Expense) | -55.00M | 60.20M | 15.50M | -32.20M | 15.50M | -226.30M | -225.30M | -57.40M | -227.70M | -197.00M |
| Pretax Income | 728.90M | 629.70M | 504.00M | 1.10B | 2.46B | 1.85B | 784.40M | 937.70M | 838.80M | 884.50M |
| Income Tax | 229.80M | 212.40M | 188.50M | 233.90M | 690.00M | 662.10M | 280.00M | 384.40M | -155.40M | 360.70M |
| Net Income | 876.50M | 746.00M | 418.00M | 1.28B | 2.38B | 1.56B | 823.80M | 883.70M | 1.23B | 711.80M |
| Net Income growth (YoY) | +17.49% | +78.47% | -67.32% | -46.20% | +52.77% | +88.89% | -6.78% | -27.98% | +72.39% | +62.66% |
| EPS (Basic) | 10.54 | 8.89 | 4.80 | 14.05 | 24.60 | 15.99 | 8.42 | 8.71 | 11.99 | 6.94 |
| EPS (Diluted) | 10.46 | 8.84 | 4.77 | 13.97 | 24.39 | 15.88 | 8.35 | 8.61 | 11.81 | 6.82 |
| Shares Outstanding (Basic) | 83.20M | 83.90M | 87.10M | 91.10M | 96.70M | 97.30M | 97.90M | 101.40M | 102.40M | 102.50M |
| Shares Outstanding (Diluted) | 83.80M | 84.40M | 87.60M | 91.60M | 97.50M | 98.00M | 98.60M | 102.60M | 103.90M | 104.30M |
| EBITDA | 2.07B | 1.73B | 1.30B | 1.97B | 3.63B | 3.07B | 1.91B | 1.88B | 1.84B | 1.77B |
| Gross Margin | 28.76% | 27.86% | 27.67% | 31.26% | 38.01% | 35.43% | 28.15% | 28.03% | 29.99% | 29.88% |
| Operating Margin | 9.92% | 8.35% | 5.97% | 12.11% | 23.21% | 17.49% | 11.51% | 11.70% | 12.66% | 13.30% |
| Net Margin | 6.28% | 5.73% | 3.44% | 10.78% | 18.10% | 11.13% | 7.13% | 7.80% | 11.90% | 7.45% |
This table shows 10 annual periods of Labcorp's income statement, from FY 2025 back to FY 2016, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow LH's reporting calendar. What is a income statement?